These healthcare stocks have the highest EPS revision grade ahead of Q3 results
at seekingalpha.com (Fri, 9-Oct 9:05 AM)
Olorofim vs. AmBisome: A Phase III Antifungal Trial With Implications for IQVIA Holdings (IQV)
at www.tipranks.com (Thu, 8-Oct 12:30 PM)
UBS flags 56 stocks where growth and profitability may be underpriced
at seekingalpha.com (Thu, 8-Oct 6:29 AM)
Market Chameleon (Wed, 5-Aug 9:50 AM)
Record R&D Bookings and Cash Flow Support IQVIA’s Upbeat Guidance for 2026
Market Chameleon (Tue, 28-Jul 11:07 AM)
IQVIA Raises 2026 Guidance on Record R&D Bookings and Robust Cash Flow
Market Chameleon (Tue, 28-Jul 7:31 AM)
